China SXT Pharmaceuticals Inc (SXTC) Actualités

Form EFFECT - Notice of Effectiveness

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form F-3 - Registration statement by foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Jiangsu, China, , Oct. 07, 2024 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form NT 20-F - Notification of inability to timely file Form 20-F

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form S-8 - Securities to be offered to employees in employee benefit plans

China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule

TAIZHOU, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company...

China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split

TAIZHOU, China, Oct. 04, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   AMENDMENT...

China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

TAIZHOU, China, May 10, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company...

Statement of Ownership (sc 13g)

 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 13G  Under the Securities Exchange...